| Expression of the c-erbB2 proto-oncogene in male breast carcinoma: lack of prognostic significance. | breast, |
| Antibody response against the c-erbB-2 oncoprotein in breast carcinoma patients. | breast, |
| Immunohistochemical study on the expression of c-erbB-2 oncoprotein in breast cancer. | breast, |
| Increased natural killer cell activity correlates with low or negative expression of the HER-2/neu oncogene in patients with breast cancer. | breast, |
| Receptor status, proliferating activity, and c-erbB2 oncoprotein. An immunocytochemical evaluation in breast cancer. | breast, |
| Detection of HER-2 oncogene amplification in breast cancer by differential polymerase chain reaction from single cryosections. | breast, |
| Elevated erbB-2 oncoprotein levels in preoperative and follow-up serum samples define an aggressive disease course in patients with breast cancer. | breast, |
| ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix. | uterine, |
| Expression of the c-erbB-2-encoded oncoprotein and progesterone receptor in human meningiomas. | meningiomas, |
| Lymphoepithelioma-like carcinoma of the uterine cervix with c-erbB-2, p53 oncoprotein expression and DNA quantification. | uterine, |
| Overexpression of the oncogene c-erb B2 in primary ovarian cancer: evaluation of the prognostic value in a Cox proportional hazards multiple regression. | ovarian, |
| A new high frequency polymorphism in the HER-2/neu oncogene in normal tissue and breast tumors. | breast, |
| Immunohistochemical demonstration of c-erbB-2 oncoprotein in gastric adenocarcinoma: comparison of cryostat and paraffin wax sections and effect of fixation. | gastric, |
| Expression of HER-2/neu oncoprotein and epidermal growth factor receptor and prognosis in gastric carcinoma. | gastric, |
| Elevated serum levels of a c-erbB-2 oncogene product in ovarian cancer patients and in pregnancy. | ovarian, |
| Chemotherapeutic inhibition of erb-B2 oncogene expression on a non-small-cell cancer line (NSCLC-N6) by marine substances. | lung, |
| Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy. | breast, |
| [Study of Her-2/neu oncogene in relation to prognosis of human breast cancer]. | breast, |
| [Gene expression of TGF alpha, TGF beta 1 and C-erbB2 oncogene in human pancreatic carcinoma cell lines]. | pancreatic, |
| What s new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease. | breast, |